1. ALLA AKTIER
  2. NYHETER
  3. PROLIGHT DIAGNOSTICS

Prolight Diagnostics

Nyheter Prolight Diagnostics Nyheter alla bolag
Slipp dessa annonser och få en massa andra godsaker med vårt premiumabonnemang.

Emergers publishes updated analysis about Prolight Diagnostics

Emergers publishes updated analysis about Prolight DIagnostics with the title: ”Gearing up for commercialisation with strong insider backing”.
 
Among others, the article describes ”Strong insider commitment signals confidence” and that Prolight is ”Well-positioned for strategic partnering in 2025”
 
Read the article here: https://www.emergers.se/prolight-j25/

For further information, please contact:
Ulf Bladin, CEO
E-mail: info@prolightdx.com
Phone: +46 73 582 39 87
Company website: www.prolightdx.com

About Us
Prolight Diagnostics AB develops innovative Point-of-Care (POC) systems. These are small, portable instruments and disposable cartridges for performing in-vitro diagnostic (IVD) tests from a drop of blood.
We want to offer the foremost POC systems on the market for quick, reliable diagnosis of acute events. Our launch product will be for the measurement of troponin, to aid in the rule-in and rule-out of myocardial infarction.
 
The company’s share is traded on the NGM Nordic SME marketplace, under the ticker PRLD.

Attachments
Emergers publishes updated analysis about Prolight Diagnostics

Datum 2025-05-23, kl 08:25
Källa MFN
Bifogade filer
Emergers publishes updated analysis about Prolight Diagnostics